BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25557911)

  • 1. Cyclin F suppresses B-Myb activity to promote cell cycle checkpoint control.
    Klein DK; Hoffmann S; Ahlskog JK; O'Hanlon K; Quaas M; Larsen BD; Rolland B; Rösner HI; Walter D; Kousholt AN; Menzel T; Lees M; Johansen JV; Rappsilber J; Engeland K; Sørensen CS
    Nat Commun; 2015 Jan; 6():5800. PubMed ID: 25557911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation and activation of B-Myb by cyclin A-Cdk2.
    Ziebold U; Bartsch O; Marais R; Ferrari S; Klempnauer KH
    Curr Biol; 1997 Apr; 7(4):253-60. PubMed ID: 9094315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of B-Myb by ubiquitin-mediated proteolysis: involvement of the Cdc34-SCF(p45Skp2) pathway.
    Charrasse S; Carena I; Brondani V; Klempnauer KH; Ferrari S
    Oncogene; 2000 Jun; 19(26):2986-95. PubMed ID: 10871850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cell cycle regulation after exposure to ionizing radiation].
    Teyssier F; Bay JO; Dionet C; Verrelle P
    Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-Myb promotes S-phase independently of its sequence-specific DNA binding activity and interacts with polymerase delta-interacting protein 1 (Pdip1).
    Werwein E; Schmedt T; Hoffmann H; Usadel C; Obermann N; Singer JD; Klempnauer KH
    Cell Cycle; 2012 Nov; 11(21):4047-58. PubMed ID: 23032261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of human B-MYB by cyclins.
    Sala A; Kundu M; Casella I; Engelhard A; Calabretta B; Grasso L; Paggi MG; Giordano A; Watson RJ; Khalili K; Peschle C
    Proc Natl Acad Sci U S A; 1997 Jan; 94(2):532-6. PubMed ID: 9012818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin F-dependent degradation of E2F7 is critical for DNA repair and G2-phase progression.
    Yuan R; Liu Q; Segeren HA; Yuniati L; Guardavaccaro D; Lebbink RJ; Westendorp B; de Bruin A
    EMBO J; 2019 Oct; 38(20):e101430. PubMed ID: 31475738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PARP co-activates B-MYB through enhanced phosphorylation at cyclin/cdk2 sites.
    Santilli G; Cervellera MN; Johnson TK; Lewis RE; Iacobelli S; Sala A
    Oncogene; 2001 Dec; 20(57):8167-74. PubMed ID: 11781832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-Myb participated in ionizing radiation-induced apoptosis and cell cycle arrest in human glioma cells.
    Shen X; Cao H; Zhu Y; Zhao Y; Liu Y; Zuo W; Lin F; Liang Z
    Biochem Biophys Res Commun; 2021 Oct; 573():19-26. PubMed ID: 34375765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDC1 is a mediator of the mammalian DNA damage checkpoint.
    Stewart GS; Wang B; Bignell CR; Taylor AM; Elledge SJ
    Nature; 2003 Feb; 421(6926):961-6. PubMed ID: 12607005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin F is degraded during G2-M by mechanisms fundamentally different from other cyclins.
    Fung TK; Siu WY; Yam CH; Lau A; Poon RY
    J Biol Chem; 2002 Sep; 277(38):35140-9. PubMed ID: 12122006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-TrCP- and Casein Kinase II-Mediated Degradation of Cyclin F Controls Timely Mitotic Progression.
    Mavrommati I; Faedda R; Galasso G; Li J; Burdova K; Fischer R; Kessler BM; Carrero ZI; Guardavaccaro D; Pagano M; D'Angiolella V
    Cell Rep; 2018 Sep; 24(13):3404-3412. PubMed ID: 30257202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive expression of B-myb can bypass p53-induced Waf1/Cip1-mediated G1 arrest.
    Lin D; Fiscella M; O'Connor PM; Jackman J; Chen M; Luo LL; Sala A; Travali S; Appella E; Mercer WE
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):10079-83. PubMed ID: 7937841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of B-Myb activity by cyclin D1.
    Horstmann S; Ferrari S; Klempnauer KH
    Oncogene; 2000 Jan; 19(2):298-306. PubMed ID: 10645009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-MYB is required for recovery from the DNA damage-induced G2 checkpoint in p53 mutant cells.
    Mannefeld M; Klassen E; Gaubatz S
    Cancer Res; 2009 May; 69(9):4073-80. PubMed ID: 19383908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different cyclin types collaborate to reverse the S-phase checkpoint and permit prompt mitosis.
    Yuan K; Farrell JA; O'Farrell PH
    J Cell Biol; 2012 Sep; 198(6):973-80. PubMed ID: 22965907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay with the Mre11-Rad50-Nbs1 complex and phosphorylation by GSK3β implicate human B-Myb in DNA-damage signaling.
    Henrich SM; Usadel C; Werwein E; Burdova K; Janscak P; Ferrari S; Hess D; Klempnauer KH
    Sci Rep; 2017 Jan; 7():41663. PubMed ID: 28128338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the cyclin D1 and cyclin A1 promoters by B-Myb is mediated by Sp1 binding sites.
    Bartusel T; Schubert S; Klempnauer KH
    Gene; 2005 May; 351():171-80. PubMed ID: 15922873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A functional interaction of E7 with B-Myb-MuvB complex promotes acute cooperative transcriptional activation of both S- and M-phase genes. (129 c).
    Pang CL; Toh SY; He P; Teissier S; Ben Khalifa Y; Xue Y; Thierry F
    Oncogene; 2014 Jul; 33(31):4039-49. PubMed ID: 24141769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammalian Mip/LIN-9 interacts with either the p107, p130/E2F4 repressor complex or B-Myb in a cell cycle-phase-dependent context distinct from the Drosophila dREAM complex.
    Pilkinton M; Sandoval R; Colamonici OR
    Oncogene; 2007 Nov; 26(54):7535-43. PubMed ID: 17563750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.